Efavirenz concentrations and probability of HIV replication in children
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. In 188 HIV-infected children receiving efavirenz, a lower middose (C12) was associated with a higher risk of HIV-1 viral load >400 copies/ mL (P = 0.03). Simulations for a normalized population receiving US Food and Drug Administra...
Saved in:
Main Authors: | Nontiya Homkham, Tim R. Cressey, Naïm Bouazza, Chulapong Chanta, Linda Aurpibul, Thition Narkbunnam, Sawitree Krikajornkitti, Nareerat Kamonpakorn, Marc Lallemant, Lily Ingsrisawang, Nicolas Salvadori, Jean Marc Treluyer, Saik Urien, Gonzague Jourdain |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84944217669&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54817 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Efavirenz concentrations and probability of HIV replication in children
by: Nontiya Homkham, et al.
Published: (2018) -
Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children
by: Nontiya Homkham, et al.
Published: (2019) -
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
by: Nontiya Homkham, et al.
Published: (2018) -
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
by: Homkham N., et al.
Published: (2017) -
Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
by: Naïm Bouazza, et al.
Published: (2018)